SC 13G | 2024-04-26 | Deep Track Capital, LP | INOVIO PHARMACEUTICALS, INC. | 2,593,822 | 10.0% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | INOVIO PHARMACEUTICALS, INC. | 19,766,042 | 7.2% | EDGAR |
SC 13G/A | 2024-01-22 | STATE STREET CORP | INOVIO PHARMACEUTICALS, INC. | - | 0.3% | EDGAR |
SC 13G/A | 2023-07-10 | STATE STREET CORP | INOVIO PHARMACEUTICALS, INC. | - | 0.3% | EDGAR |
SC 13G/A | 2023-07-07 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 6,086,623 | 2.3% | EDGAR |
SC 13G/A | 2023-02-09 | STATE STREET CORP | INOVIO PHARMACEUTICALS, INC. | - | 12.6% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | INOVIO PHARMACEUTICALS, INC. | 17,042,500 | 6.8% | EDGAR |
SC 13G/A | 2023-01-24 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 23,284,119 | 9.3% | EDGAR |
SC 13G/A | 2022-04-11 | STATE STREET CORP | INOVIO PHARMACEUTICALS, INC. | - | 10.5% | EDGAR |
SC 13G/A | 2022-02-11 | STATE STREET CORP | INOVIO PHARMACEUTICALS, INC. | - | 6.3% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | INOVIO PHARMACEUTICALS, INC. | 11,039,313 | 5.2% | EDGAR |
SC 13G/A | 2022-02-01 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 18,244,914 | 8.7% | EDGAR |
SC 13G/A | 2021-02-11 | WASATCH ADVISORS INC | INOVIO PHARMACEUTICALS, INC. | - | - | EDGAR |
SC 13G/A | 2021-02-11 | Nikko Asset Management Americas, Inc. | INOVIO PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | INOVIO PHARMACEUTICALS, INC. | 9,185,639 | 5.4% | EDGAR |
SC 13G | 2021-02-10 | STATE STREET CORP | INOVIO PHARMACEUTICALS, INC. | - | 5.2% | EDGAR |
SC 13G/A | 2021-02-05 | Sumitomo Mitsui Trust Holdings, Inc. | INOVIO PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | INOVIO PHARMACEUTICALS, INC. | 14,242,941 | 8.4% | EDGAR |
SC 13G | 2020-02-12 | Nikko Asset Management Americas, Inc. | INOVIO PHARMACEUTICALS, INC. | 5,047,608 | 5.0% | EDGAR |
SC 13G | 2020-02-12 | Sumitomo Mitsui Trust Holdings, Inc. | INOVIO PHARMACEUTICALS, INC. | 5,047,608 | 5.0% | EDGAR |